Nadroparin for the Initial Treatment of Pulmonary Thromboembolism

NCT00796692 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

274

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Embolism
Thromboembolism
Vascular Diseases
Thrombosis

Interventions

DRUG: Nadroparin
DRUG: Unfractionated heparin(UFH)

Sponsor

Beijing Chao Yang Hospital